Tranche Update on The Cooper Companies, Inc.'s Equity Buyback Plan announced on December 15, 2011.
March 04, 2021 at 09:19 pm
Share
From November 1, 2020 to January 31, 2021, the company has repurchased 69,622 shares, representing 0.14% for $24.83 million. With this, the company has completed the repurchase of 4,469,177 shares, representing 9.21% for $665.23 million under the buyback announced on December 15, 2011.
The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVisionâs products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and womenâs health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within womenâs health. CooperSurgicalâs brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.